Erik Neu
Vice President at Ssi Strategy
Based in United States
7-day free trial · no credit card
Seniority
Vp
Department
General Business & Management
Location
United States
Industry
Business Consulting and Services
Company size
194
Contact information
Reveal Erik's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
e•••••••@ssistrategy.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Erik Neu
Vice President, Business Consulting at SSI Strategy | Building Better BiotechsI help biotech and life sciences companies bridge the gap between strategy and execution. As a Vice President at SSI Strategy, I assemble and lead cross-functional teams that help our clients see around corners to align strategic, scientific, and operational goals to avoid the common and not-so-common costly pitfalls that slow or derail development.I’ve spent 25 years in management consulting, the last 15 focused on life sciences and biotech. SSI’s capabilities fully serve the Development of a therapy from Translational Science to Launch Readiness. At SSI, we live and breathe the connection points between Clinical Development, Clinical Operations, Drug Safety, Regulatory Affairs, Medical Affairs, Market Access, and Quality systems. We understand how siloed expertise adds drag to progress, delays milestones, and burns through runway. You need people that know the process end-to-end and can help in precisely the right places at the right level at the right time. While I engage clients and manage teams across all of SSI’s services, I lead SSI Strategy’s Medical Affairs discipline: our business strategy, service offerings, and go-to-market approach. With my MD counterparts we steer and manage our global team of MD, PhD, and PharmD Medical Affairs experts to ensure we deliver cohesive, high-impact solutions for clients.For biotechs beginning a transition to commercialization, SSI Strategy Medical Affairs will help you determine your Medical Strategy, staffing needs and tactical mix. We will provide fractional resources to build your organization as a bridge to your hiring plan.For companies looking to partner out for launch, or to sell an asset, we work with you to maximize the due diligence value of your therapy through targeted external validation of your refined scientific narrative and value proposition. For companies that are facing a launch in the next 12-18 months through acquisition or program acceleration, we offer Just-in-Time launch prep, capabilities building, and triage support to get you where you need to be, fast.Our mission is clear: Build better biotechs through seamless collaboration, informed decision-making, and accelerated progress.
Decision-makers
Other people at Ssi Strategy
- LPManager
Laura Prout
Manager-operations · Operations
- MDVp
Matthew Divack
Vice President · General Business & Management
- NJManager
Natalie Japlon
Engagement Manager · General Business & Management
- AMOther
Allyson Morton
Senior Director - Pharmacovigilance / Clinical Science at SSI Strategy · Other
- GKManager
Gina Kackloudis
Clinical Operations Consultant · Operations
Build a list of verified contacts at Ssi Strategy
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Erik
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime